位置:首页 > 蛋白库 > BFSP1_HUMAN
BFSP1_HUMAN
ID   BFSP1_HUMAN             Reviewed;         665 AA.
AC   Q12934; F5H0G1; O43595; O76034; O95676; Q8IVZ6; Q9HBX4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2001, sequence version 3.
DT   03-AUG-2022, entry version 185.
DE   RecName: Full=Filensin;
DE   AltName: Full=Beaded filament structural protein 1;
DE   AltName: Full=Lens fiber cell beaded-filament structural protein CP 115;
DE            Short=CP115;
DE   AltName: Full=Lens intermediate filament-like heavy;
DE            Short=LIFL-H;
DE   Contains:
DE     RecName: Full=Filensin C-terminal fragment {ECO:0000303|PubMed:30790544};
DE   Contains:
DE     RecName: Full=Filensin N-terminal fragment {ECO:0000250|UniProtKB:Q06002};
GN   Name=BFSP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9628810; DOI=10.1006/exer.1998.0478;
RA   Hess J.F., Casselman J.T., Kong A.P., FitzGerald P.G.;
RT   "Primary sequence, secondary structure, gene structure, and assembly
RT   properties suggests that the lens-specific cytoskeletal protein filensin
RT   represents a novel class of intermediate filament protein.";
RL   Exp. Eye Res. 66:625-644(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=9787085; DOI=10.1006/geno.1998.5478;
RA   Rendtorff N.D., Hansen C., Silahtaroglu A., Henriksen K.F., Tommerup N.;
RT   "Isolation of the human beaded-filament structural protein 1 gene (BFSP1)
RT   and assignment to chromosome 20p11.23-p12.1.";
RL   Genomics 53:114-116(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 120-249, AND TISSUE SPECIFICITY.
RC   TISSUE=Lens;
RX   PubMed=7720401; DOI=10.3109/02713689508999909;
RA   Hess J.F., Casselman J.T., FitzGerald P.G.;
RT   "Chromosomal locations of the genes for the beaded filament proteins CP 115
RT   and CP 47.";
RL   Curr. Eye Res. 14:11-18(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-178.
RX   PubMed=10909854; DOI=10.1038/sj.ejhg.5200485;
RA   Yamada K., Tomita H., Yoshiura K., Kondo S., Wakui K., Fukushima Y.,
RA   Ikegawa S., Nakamura Y., Amemiya T., Niikawa N.;
RT   "An autosomal dominant posterior polar cataract locus maps to human
RT   chromosome 20p12-q12.";
RL   Eur. J. Hum. Genet. 8:535-539(2000).
RN   [7]
RP   INVOLVEMENT IN CTRCT33.
RX   PubMed=17225135; DOI=10.1007/s00439-006-0319-6;
RA   Ramachandran R.D., Perumalsamy V., Hejtmancik J.F.;
RT   "Autosomal recessive juvenile onset cataract associated with mutation in
RT   BFSP1.";
RL   Hum. Genet. 121:475-482(2007).
RN   [8]
RP   FUNCTION, AND IDENTIFICATION IN A COMPLEX WITH BFSP2 AND CRYAA.
RX   PubMed=28935373; DOI=10.1016/j.bbrc.2017.09.088;
RA   Chaves J.M., Gupta R., Srivastava K., Srivastava O.;
RT   "Human alpha A-crystallin missing N-terminal domain poorly complexes with
RT   filensin and phakinin.";
RL   Biochem. Biophys. Res. Commun. 494:402-408(2017).
RN   [9]
RP   INVOLVEMENT IN CTRCT33.
RX   PubMed=28450710; DOI=10.1038/s41598-017-01182-9;
RA   Zhai Y., Li J., Yu W., Zhu S., Yu Y., Wu M., Sun G., Gong X., Yao K.;
RT   "Targeted exome sequencing of congenital cataracts related genes:
RT   broadening the mutation spectrum and genotype-phenotype correlations in 27
RT   Chinese Han families.";
RL   Sci. Rep. 7:1219-1219(2017).
RN   [10]
RP   FUNCTION, TISSUE SPECIFICITY, MYRISTOYLATION AT GLY-434, PROTEOLYTIC
RP   CLEAVAGE, AND MUTAGENESIS OF ASP-433 AND GLY-434.
RX   PubMed=30790544; DOI=10.1016/j.exer.2019.02.001;
RA   Tapodi A., Clemens D.M., Uwineza A., Goldberg M.W., Thinon E., Heal W.P.,
RA   Tate E.W., Nemeth-Cahalan K., Vorontsova I., Jarrin M., Hall J.E.,
RA   Quinlan R.A.;
RT   "BFSP1 C-terminal domains released by post-translational processing events
RT   can alter significantly the calcium regulation of AQP0 water
RT   permeability.";
RL   Exp. Eye Res. 185:107585-107585(2019).
RN   [11]
RP   VARIANT CTRCT33 ASN-348.
RX   PubMed=24379646;
RA   Wang H., Zhang T., Wu D., Zhang J.;
RT   "A novel beaded filament structural protein 1 (BFSP1) gene mutation
RT   associated with autosomal dominant congenital cataract in a Chinese
RT   family.";
RL   Mol. Vis. 19:2590-2595(2013).
CC   -!- FUNCTION: Required for the correct formation of lens intermediate
CC       filaments as part of a complex composed of BFSP1, BFSP2 and CRYAA
CC       (PubMed:28935373). Involved in altering the calcium regulation of MIP
CC       water permeability (PubMed:30790544). {ECO:0000269|PubMed:28935373,
CC       ECO:0000269|PubMed:30790544}.
CC   -!- SUBUNIT: Part of a complex required for lens intermediate filament
CC       formation composed of BFSP1, BFSP2 and CRYAA (PubMed:28935373).
CC       Identified in a complex that contains VIM, EZR, AHNAK, BFSP1, BFSP2,
CC       ANK2, PLEC, PRX and spectrin (By similarity). Found in a complex
CC       composed of PPL (via C-terminal linker domain), BFSP1 and BFSP2 in the
CC       retinal lens (By similarity). Within the complex interacts with BFSP2
CC       (By similarity). Interacts (via C-terminus) with MIP (via C-terminus)
CC       in aged lens fiber cells (By similarity).
CC       {ECO:0000250|UniProtKB:A2AMT1, ECO:0000250|UniProtKB:Q06002,
CC       ECO:0000269|PubMed:28935373}.
CC   -!- INTERACTION:
CC       Q12934; P37198: NUP62; NbExp=3; IntAct=EBI-10227494, EBI-347978;
CC       Q12934-2; Q13515: BFSP2; NbExp=5; IntAct=EBI-12123320, EBI-10229433;
CC       Q12934-2; Q13895: BYSL; NbExp=3; IntAct=EBI-12123320, EBI-358049;
CC       Q12934-2; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-12123320, EBI-10175300;
CC       Q12934-2; Q9Y6C2-2: EMILIN1; NbExp=3; IntAct=EBI-12123320, EBI-11748557;
CC       Q12934-2; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-12123320, EBI-14069005;
CC       Q12934-2; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-12123320, EBI-3044087;
CC       Q12934-2; P37198: NUP62; NbExp=3; IntAct=EBI-12123320, EBI-347978;
CC       Q12934-2; O95295: SNAPIN; NbExp=3; IntAct=EBI-12123320, EBI-296723;
CC       Q12934-2; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-12123320, EBI-739895;
CC       Q12934-2; O95229: ZWINT; NbExp=3; IntAct=EBI-12123320, EBI-1001132;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q06002};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q06002}; Cytoplasmic
CC       side {ECO:0000250|UniProtKB:Q06002}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q02435}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q06002}. Cytoplasm, cell cortex
CC       {ECO:0000250|UniProtKB:Q06002}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q12934-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12934-2; Sequence=VSP_024921, VSP_024922;
CC       Name=3;
CC         IsoId=Q12934-3; Sequence=VSP_055064;
CC   -!- TISSUE SPECIFICITY: Expressed in the cortex and nucleus of the retina
CC       lens (at protein level). {ECO:0000269|PubMed:30790544,
CC       ECO:0000269|PubMed:7720401}.
CC   -!- PTM: Proteolytically cleaved during lens cell fiber differentiation
CC       with increased fragmentation as fiber cell age increases.
CC       {ECO:0000250|UniProtKB:Q06002}.
CC   -!- PTM: [Filensin C-terminal fragment]: Myristoylated at Gly-434 following
CC       proteolytic cleavage at Asp-433. {ECO:0000269|PubMed:30790544}.
CC   -!- PTM: [Filensin N-terminal fragment]: Acetylated at Ala-42 following
CC       proteolytic cleavage at Leu-41. {ECO:0000250|UniProtKB:Q06002}.
CC   -!- DISEASE: Cataract 33, multiple types (CTRCT33) [MIM:611391]: An
CC       opacification of the crystalline lens of the eye that frequently
CC       results in visual impairment or blindness. Opacities vary in
CC       morphology, are often confined to a portion of the lens, and may be
CC       static or progressive. In general, the more posteriorly located and
CC       dense an opacity, the greater the impact on visual function. CTRCT33
CC       has juvenile-onset and the opacities are restricted to the cortex of
CC       the lens, not involving the nucleus. {ECO:0000269|PubMed:17225135,
CC       ECO:0000269|PubMed:24379646, ECO:0000269|PubMed:28450710}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA76349.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF039655; AAB94939.1; -; mRNA.
DR   EMBL; Y16717; CAA76348.1; -; mRNA.
DR   EMBL; Y16718; CAA76349.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; Y16719; CAA76349.1; JOINED; Genomic_DNA.
DR   EMBL; Y16720; CAA76349.1; JOINED; Genomic_DNA.
DR   EMBL; Y16722; CAA76349.1; JOINED; Genomic_DNA.
DR   EMBL; Y16723; CAA76349.1; JOINED; Genomic_DNA.
DR   EMBL; Y16721; CAA76349.1; JOINED; Genomic_DNA.
DR   EMBL; AL031664; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL132765; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC041483; AAH41483.1; -; mRNA.
DR   EMBL; U12622; AAA74423.1; -; mRNA.
DR   EMBL; AH009849; AAG17186.1; -; Genomic_DNA.
DR   CCDS; CCDS13126.1; -. [Q12934-1]
DR   CCDS; CCDS54448.1; -. [Q12934-2]
DR   CCDS; CCDS63229.1; -. [Q12934-3]
DR   PIR; I38730; I38730.
DR   RefSeq; NP_001155177.1; NM_001161705.1. [Q12934-2]
DR   RefSeq; NP_001186.1; NM_001195.4. [Q12934-1]
DR   RefSeq; NP_001265535.1; NM_001278606.1. [Q12934-3]
DR   RefSeq; NP_001265536.1; NM_001278607.1.
DR   RefSeq; NP_001265537.1; NM_001278608.1. [Q12934-3]
DR   AlphaFoldDB; Q12934; -.
DR   SMR; Q12934; -.
DR   BioGRID; 107100; 46.
DR   IntAct; Q12934; 15.
DR   STRING; 9606.ENSP00000367104; -.
DR   iPTMnet; Q12934; -.
DR   PhosphoSitePlus; Q12934; -.
DR   BioMuta; BFSP1; -.
DR   DMDM; 17372543; -.
DR   jPOST; Q12934; -.
DR   MassIVE; Q12934; -.
DR   PaxDb; Q12934; -.
DR   PeptideAtlas; Q12934; -.
DR   PRIDE; Q12934; -.
DR   ProteomicsDB; 25331; -.
DR   ProteomicsDB; 59039; -. [Q12934-1]
DR   ProteomicsDB; 59040; -. [Q12934-2]
DR   Antibodypedia; 9222; 287 antibodies from 29 providers.
DR   DNASU; 631; -.
DR   Ensembl; ENST00000377868.6; ENSP00000367099.2; ENSG00000125864.14. [Q12934-2]
DR   Ensembl; ENST00000377873.8; ENSP00000367104.3; ENSG00000125864.14. [Q12934-1]
DR   Ensembl; ENST00000536626.7; ENSP00000442522.1; ENSG00000125864.14. [Q12934-3]
DR   GeneID; 631; -.
DR   KEGG; hsa:631; -.
DR   MANE-Select; ENST00000377873.8; ENSP00000367104.3; NM_001195.5; NP_001186.1.
DR   UCSC; uc002wpo.4; human. [Q12934-1]
DR   CTD; 631; -.
DR   DisGeNET; 631; -.
DR   GeneCards; BFSP1; -.
DR   HGNC; HGNC:1040; BFSP1.
DR   HPA; ENSG00000125864; Low tissue specificity.
DR   MalaCards; BFSP1; -.
DR   MIM; 603307; gene.
DR   MIM; 611391; phenotype.
DR   neXtProt; NX_Q12934; -.
DR   OpenTargets; ENSG00000125864; -.
DR   Orphanet; 98991; Early-onset nuclear cataract.
DR   PharmGKB; PA25343; -.
DR   VEuPathDB; HostDB:ENSG00000125864; -.
DR   eggNOG; ENOG502QRCH; Eukaryota.
DR   GeneTree; ENSGT00390000016976; -.
DR   HOGENOM; CLU_028949_0_0_1; -.
DR   InParanoid; Q12934; -.
DR   OMA; MIVETMI; -.
DR   OrthoDB; 677568at2759; -.
DR   PhylomeDB; Q12934; -.
DR   TreeFam; TF331671; -.
DR   PathwayCommons; Q12934; -.
DR   SignaLink; Q12934; -.
DR   BioGRID-ORCS; 631; 14 hits in 1073 CRISPR screens.
DR   ChiTaRS; BFSP1; human.
DR   GeneWiki; BFSP1; -.
DR   GenomeRNAi; 631; -.
DR   Pharos; Q12934; Tbio.
DR   PRO; PR:Q12934; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q12934; protein.
DR   Bgee; ENSG00000125864; Expressed in tendon of biceps brachii and 117 other tissues.
DR   Genevisible; Q12934; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005212; F:structural constituent of eye lens; IBA:GO_Central.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0045109; P:intermediate filament organization; ISS:UniProtKB.
DR   GO; GO:0070307; P:lens fiber cell development; IBA:GO_Central.
DR   InterPro; IPR042358; BFSP1.
DR   InterPro; IPR039008; IF_rod_dom.
DR   PANTHER; PTHR14069; PTHR14069; 1.
DR   Pfam; PF00038; Filament; 1.
DR   SMART; SM01391; Filament; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cataract; Cell membrane; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Eye lens protein; Intermediate filament;
KW   Lipoprotein; Membrane; Myristate; Phosphoprotein; Reference proteome;
KW   Repeat.
FT   CHAIN           1..665
FT                   /note="Filensin"
FT                   /id="PRO_0000063847"
FT   CHAIN           42..433
FT                   /note="Filensin N-terminal fragment"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT                   /id="PRO_0000448670"
FT   CHAIN           434..665
FT                   /note="Filensin C-terminal fragment"
FT                   /evidence="ECO:0000269|PubMed:30790544"
FT                   /id="PRO_0000448671"
FT   DOMAIN          40..320
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..40
FT                   /note="Head"
FT   REGION          41..75
FT                   /note="Coil 1A"
FT   REGION          76..84
FT                   /note="Linker 1"
FT   REGION          85..184
FT                   /note="Coil 1B"
FT   REGION          185..201
FT                   /note="Linker 12"
FT   REGION          202..320
FT                   /note="Coil 2"
FT   REGION          321..665
FT                   /note="Tail"
FT   REGION          410..439
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          506..614
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        536..572
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            41..42
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT   SITE            433..434
FT                   /note="Cleavage (by CASP2, CASP3, and CASP7)"
FT                   /evidence="ECO:0000269|PubMed:30790544"
FT   SITE            457
FT                   /note="Interaction with MIP"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT   MOD_RES         5
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT   MOD_RES         42
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT   MOD_RES         420
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT   MOD_RES         513
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT   MOD_RES         665
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06002"
FT   LIPID           434
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:30790544"
FT   VAR_SEQ         1..139
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_055064"
FT   VAR_SEQ         1..125
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_024921"
FT   VAR_SEQ         126
FT                   /note="K -> M (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_024922"
FT   VARIANT         345
FT                   /note="G -> S (in dbSNP:rs6080719)"
FT                   /id="VAR_024492"
FT   VARIANT         348
FT                   /note="D -> N (in CTRCT33; dbSNP:rs1085307126)"
FT                   /evidence="ECO:0000269|PubMed:24379646"
FT                   /id="VAR_078861"
FT   VARIANT         656
FT                   /note="D -> E (in dbSNP:rs16999317)"
FT                   /id="VAR_036683"
FT   MUTAGEN         433
FT                   /note="D->A: Abolishes cleavage by CASP2."
FT                   /evidence="ECO:0000269|PubMed:30790544"
FT   MUTAGEN         434
FT                   /note="G->A: No effect on cleavage."
FT                   /evidence="ECO:0000269|PubMed:30790544"
FT   CONFLICT        96
FT                   /note="R -> P (in Ref. 6; AAG17186)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176..177
FT                   /note="HK -> TR (in Ref. 5; AAA74423)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="T -> A (in Ref. 5; AAA74423)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        398
FT                   /note="K -> R (in Ref. 1; AAB94939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        568
FT                   /note="E -> G (in Ref. 1; AAB94939)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   665 AA;  74544 MW;  A99FE174A8B63E9C CRC64;
     MYRRSYVFQT RKEQYEHADE ASRAAEPERP ADEGWAGATS LAALQGLGER VAAHVQRARA
     LEQRHAGLRR QLDAFQRLGE LAGPEDALAR QVESNRQRVR DLEAERARLE RQGTEAQRAL
     DEFRSKYENE CECQLLLKEM LERLNKEADE ALLHNLRLQL EAQFLQDDIS AAKDRHKKNL
     LEVQTYISIL QQIIHTTPPA SIVTSGMREE KLLTEREVAA LRSQLEEGRE VLSHLQAQRV
     ELQAQTTTLE QAIKSAHECY DDEIQLYNEQ IETLRKEIEE TERVLEKSSY DCRQLAVAQQ
     TLKNELDRYH RIIEIEGNRL TSAFIETPIP LFTQSHGVSL STGSGGKDLT RALQDITAAK
     PRQKALPKNV PRRKEIITKD KTNGALEDAP LKGLEDTKLV QVVLKEESES KFESESKEVS
     PLTQEGAPED VPDGGQISKG FGKLYRKVKE KVRSPKEPET PTELYTKERH VLVTGDANYV
     DPRFYVSSIT AKGGVAVSVA EDSVLYDGQV EPSPESPKPP LENGQVGLQE KEDGQPIDQQ
     PIDKEIEPDG AELEGPEEKR EGEERDEESR RPCAMVTPGA EEPSIPEPPK PAADQDGAEV
     LGTRSRSLPE KGPPKALAYK TVEVVESIEK ISTESIQTYE ETAVIVETMI GKTKSDKKKS
     GEKSS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024